FDA Accepts Bayer’s NDA for Elinzanetant to Treat Menopause Symptoms
The therapy’s Prescription Drug User Fee Act date has been set for July 26, 2025.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
Register Today: October 2024 Total Pharmacy Solutions Summit
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
Podcast: Pharmacy Financing With First Financial Bank
Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.
FDA Approves Dupixent as First Biologic Treatment for COPD
Dupixent is a fully human monoclonal antibody that inhibits the signaling of the IL4 and IL13 pathways.
Schizophrenia Drug Approved by FDA Represents First New Treatment Option in Decades
The approval of xanomeline and trospium chloride (Cobenfy) from Bristol Myers Squibb represents a “transformative moment in the treatment of schizophrenia.”
